Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:29 PM
Ignite Modification Date: 2025-12-25 @ 9:16 PM
NCT ID: NCT02371356
Description: None
Frequency Threshold: 0
Time Frame: Overall Study: Through the end of pregnancy, an average of 40 weeks
Study: NCT02371356
Study Brief: Comparing Effectiveness of Treating Depression With & Without Comorbidity to Improve Fetal Health
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Depressed, Medication Only Screen positive for depression and use only antidepressants during pregnancy 0 None 0 1320 0 1320 View
Depressed, Psychotherapy Only Screen positive for depression and receive psychotherapy only 0 None 0 7354 0 7354 View
Depressed, Medication & Psychotherapy Screen positive for depression and receive both antidepressants and psychotherapy 0 None 0 2804 0 2804 View
Depressed, Untreated Screen positive for depression and receive no treatment 0 None 0 7423 0 7423 View
Not Depressed Screen negative for depression and received no treatment 0 None 0 72183 0 72183 View
Serious Events(If Any):
Other Events(If Any):